Genetic interactions in the β-adrenoceptor/G-protein signal transduction pathway and survival after coronary artery bypass grafting: A pilot study

British Journal of Anaesthesia

Volumn 107, Issue 6, 2011, Pages 869-878

  Frey, U H ^a   Kottenberg, E ^a   Kamler, M ^b   Leineweber, K ^c   Manthey, I ^d   Heusch, G ^c   Siffert, W ^d   Peters, J ^a  

^a Klinik für Anästhesiologie und Intensivmedizin   (Germany)

^b Klinik für Thorax und kardiovaskuläre Medizin   (Germany)

^c Institut für Pathophysiologie   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

adrenergic signalling; mortality; polymorphism; signal transduction; surgery; receptor

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS SURGERY; ENZYME ACTIVITY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE INTERACTION; GENETIC RISK; GNAS GENE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MORTALITY; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

EID: 81855206555     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer302     Document Type: Article

References (34)

1. Ferguson TB Jr, Coombs LP, Peterson ED. Preoperative betablocker use and mortality and morbidity following CABG surgery in North America. J Am Med Assoc 2002; 287: 2221-7
2. Shin J, Johnson JA. Pharmacogenetics of beta-blockers. Pharmacotherapy 2007; 27: 874-87
3. Muthumala A, Drenos F, Elliott PM, Humphries SE. Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis. Eur J Heart Fail 2008; 10: 3-13
4. Leineweber K, Heusch G. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases. Br J Pharmacol 2009; 158: 61-9
5. Shin J, Lobmeyer MT, Gong Y, et al. Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. Am J Cardiol 2007; 99: 250-5
6. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. J Am Med Assoc 2005; 294: 1526-33
7. Sehnert AJ, Daniels SE, Elashoff M, et al. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. J Am Coll Cardiol 2008; 52: 644-51
8. Frey UH, Adamzik M, Kottenberg-Assenmacher E, et al. A novel functional haplotype in the human GNAS gene alters Galphas expression, responsiveness to beta-adrenoceptor stimulation, and peri-operative cardiac performance. Eur Heart J 2009; 30: 1402-10
9. Frey UH, Hauner H, Jockel KH, Manthey I, Brockmeyer N, Siffert W. A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Galphas protein expression and body weight regulation. Pharmacogenet Genomics 2008; 18: 141-51
10. Iwase M, Uechi M, Vatner DE, et al. Cardiomyopathy induced by cardiac Gs alpha overexpression. Am J Physiol 1997; 272: H585-9
11. Frey UH, Bachmann HS, Peters J, Siffert W. PCR-amplification of GC-rich regions: 'slowdown PCR'. Nat Protoc 2008; 3: 1312-7
12. Frey UH, Lieb W, Erdmann J, et al. Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans. Eur Heart J 2008; 29: 888-97
13. Adamzik M, Frey UH, Bitzer K, et al. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men. Basic Res Cardiol 2008; 103: 598-610
14. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 1974; 58: 541-8
15. Cox DR, McCullagh P. Some aspects of analysis of covariance. Biometrics 1982; 38: 541-61
16. Wand GS, Waltman C, Martin CS, McCaul ME, Levine MA, Wolfgang D. Differential expression of guanosine triphosphate binding proteins in men at high and low risk for the future development of alcoholism. J Clin Invest 1994; 94: 1004-11
17. Fox AA, Collard CD, Shernan SK, et al. Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting. Anesthesiology 2009; 110: 738-47
18. Volzke H, Engel J, Kleine V, et al. Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest 2002; 122: 31-6
19. Asai K, Yang GP, Geng YJ, et al. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse. J Clin Invest 1999; 104: 551-8
20. Vatner DE, Asai K, Iwase M, et al. Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. J Clin Invest 1998; 101: 1916-22
21. Iwase M, Bishop SP, Uechi M, et al. Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res 1996; 78: 517-24
22. Gaudin C, Ishikawa Y, Wight DC, et al. Overexpression of Gs alpha protein in the hearts of transgenic mice. J Clin Invest 1995; 95: 1676-83
23. de GP, Lamblin N, Helbecque N, et al. The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure. Eur J Heart Fail 2005; 7: 966-73
24. Biolo A, Clausell N, Santos KG, et al. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy. Am J Cardiol 2008; 102: 726-32
25. Brodde OE. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases. Fundam Clin Pharmacol 2008; 22: 107-25
26. Heckbert SR, Hindorff LA, Edwards KL, et al. Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003; 107: 2021-4
27. Yilmaz A, Kaya MG, Merdanoglu U, Ergun MA, Cengel A, Menevse S. Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction. J Clin Lab Anal 2009; 23: 237-43
28. Smiley RM, Blouin JL, Negron M, Landau R. beta2-adrenoceptor genotype affects vasopressor requirements during spinal anesthesia for cesarean delivery. Anesthesiology 2006; 104: 644-50
29. Dishy V, Sofowora GG, Xie HG, et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonistmediated vascular desensitization. N Engl J Med 2001; 345: 1030-5
30. Chong LK, Chowdry J, Ghahramani P, Peachell PT. Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 2000; 10: 153-62
31. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988; 77: 721-30
32. Brodde OE. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991; 43: 203-42
33. Nikolaev VO, Moshkov A, Lyon AR, et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010; 327: 1653-7
34. Sharma P, Bentley P. Down but not out: candidate gene-based studies still have value in a world dominated by whole genome approaches. Circ Res 2010; 106: 1019-21